Literature DB >> 4228665

Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion.

L Resnekov, L McDonald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4228665      PMCID: PMC487860          DOI: 10.1136/hrt.29.6.926

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  30 in total

1.  COMPLICATIONS AND LIMITATIONS OF DIRECT-CURRENT COUNTERSHOCK.

Authors:  M D RABBINO; W LIKOFF; L S DREIFUS
Journal:  JAMA       Date:  1964-11-02       Impact factor: 56.272

2.  CARDIOVERSION CAUSING VENTRICULAR FIBRILLATION.

Authors:  E M ROSS
Journal:  Arch Intern Med       Date:  1964-12

3.  PULMONARY OEDEMA FOLLOWING DIRECT-CURRENT DEFIBRILLATION.

Authors:  M HONEY; T T NICHOLLS; M K TOWERS
Journal:  Lancet       Date:  1965-04-03       Impact factor: 79.321

4.  LEFT ATRIAL ACTIVITY FOLLOWING CARDIOVERSION.

Authors:  W F LOGAN; D J ROWLANDS; G HOWITT; A M HOLMES
Journal:  Lancet       Date:  1965-09-04       Impact factor: 79.321

5.  Conversion of atrial fibrillation to sinus rhythm by direct-current shock.

Authors:  S ORAM; J P DAVIES; I WEINBREN; P TAGGART; L D KITCHEN
Journal:  Lancet       Date:  1963-07-27       Impact factor: 79.321

6.  Haemodynamic studies during auricular fibrillation and after restoration of sinus rhythm.

Authors:  O J BROCH; O MULLER
Journal:  Br Heart J       Date:  1957-04

7.  Serum lactic dehydrogenase; a diagnostic aid in myocardial infarction.

Authors:  R P MACDONALD; J R SIMPSON; E NOSSAL
Journal:  J Am Med Assoc       Date:  1957-09-07

8.  Lone auricular fibrillation.

Authors:  W EVANS; P SWANN
Journal:  Br Heart J       Date:  1954-04

9.  Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction.

Authors:  J S LADUE; F WROBLEWSKI; A KARMEN
Journal:  Science       Date:  1954-09-24       Impact factor: 47.728

10.  Anaesthesia for direct current shock in the treatment of cardiac arrhythmias.

Authors:  A Gilston; R Fordham; L Resnekov
Journal:  Br J Anaesth       Date:  1965-07       Impact factor: 9.166

View more
  18 in total

1.  Amplitude-duration relation for direct ventricular defibrillation with rectangular current pulses.

Authors:  G Koning; H Schneider; A J Hoelen; R S Reneman
Journal:  Med Biol Eng       Date:  1975-05

Review 2.  Atrial Fibrillation in the ICU.

Authors:  Nicholas A Bosch; Jonathan Cimini; Allan J Walkey
Journal:  Chest       Date:  2018-04-06       Impact factor: 9.410

3.  Complications of chest thump for termination of supraventricular tachycardia in children.

Authors:  G I Müller; H E Ulmer; J A Bauer
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

Review 4.  A Comparison Between NOACs and Warfarin on Time to Elective Cardioversion.

Authors:  Siva Krothapalli; Prashant D Bhave
Journal:  J Atr Fibrillation       Date:  2016-08-31

Review 5.  [Physiopathology and pathophysiology of excitation in the human heart. Findings in electrotherapy of heart rhythm disturbances].

Authors:  M Büchner
Journal:  Arch Kreislaufforsch       Date:  1969 Nov-Dec

6.  Serum enzyme activities after cardioversion.

Authors:  T Mandecki; L Giec; W Kargul
Journal:  Br Heart J       Date:  1970-09

7.  Electroversion of lone atrial fibrillation and flutter including haemodynamic studies at rest and on exercise.

Authors:  L Resnekov; L McDonald
Journal:  Br Heart J       Date:  1971-05

8.  Sustained-release quinidine (Kinidin Durules) in maintaining sinus rhythm after electroversion of atrial dysrhythmias.

Authors:  L Resnekov; D Gibson; S Waich; J Muir; L McDonald
Journal:  Br Heart J       Date:  1971-03

9.  Value of transoesophageal echocardiography before DC cardioversion in patients with atrial fibrillation: assessment of embolic risk.

Authors:  I Schnittger
Journal:  Br Heart J       Date:  1995-04

10.  Time-course of recovery of atrial contraction after cardioversion of chronic atrial fibrillation.

Authors:  H Miwa; M Arakawa; K Kagawa; T Noda; K Nishigaki; Y Ito; T Kawada; S Hirakawa
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.